🔗 Share this article

Chancellor Reeves has revealed she is planning "specific steps to address cost of living issues" in next month's Budget.

During an interview with the BBC, she stated that curbing price rises is a collective duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the G7 developed nations this calendar year and the following year.

Possible Utility Bill Measures

Reports indicate the government could intervene to bring down energy bills, for example by reducing the present 5% level of VAT applied on energy supplies.

An additional option is to cut some of the policy costs currently included in household expenses.

Budgetary Constraints and Analyst Expectations

The administration will obtain the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these measures.

The consensus from the majority of economists is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to adhere to her voluntary debt limits.

Earlier on Thursday, estimates indicated there was a £22 billion gap for the Treasury chief to address, which is at the lower end of projections.

"There's a joint responsibility between the Bank of England and the government to continue tackling some of the sources of inflation," Reeves told the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Issues

While a great deal of the focus has been on expected tax increases, the chancellor said the most recent information from the OBR had not altered her commitment to campaign commitments not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with growing international and commercial tensions for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

Global Trade Disputes

Commenting on worries about the UK's economic relations with China she said: "Our national security always come first."

Last week's declaration by China to tighten export controls on rare earths and other resources that are essential for high-technology manufacturing led US President Donald Trump to threaten an further 100% tariff on goods from China, raising the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary labeled China's action "commercial pressure" and "a international production power grab."

Questioned on considering the US offer to participate in its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Chinese government "not to put up barriers and restrict access."

She said the action was "damaging for the global economy and creates further challenges."

"In my view there are sectors where we should challenge China, but there are also valuable prospects to export to China's economy, including banking sector and other sectors of the economy. We've got to maintain that balance appropriate."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own critical minerals plan, so that we are less reliant."

NHS Medicine Pricing and Funding

Reeves also admitted that the price the National Health Service pays for medicines could go up as a result of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

Some of the biggest global drug companies have said in recent statements that they are either pausing or scrapping projects in the UK, with several attributing the insufficient payments they are obtaining.

Recently, the government science advisor said the cost the NHS pays for medicines would have to increase to prevent companies and drug research funding departing from the United Kingdom.

The Chancellor informed media: "We have seen due to the payment system, that clinical trials, new drugs have not been provided in the UK in the extent that they are in other European countries."

"The objective is to ensure that people receiving treatment from the National Health Service are can receive the finest life-saving drugs in the world. And so we are looking at this situation, and... seeking to secure additional funding into the UK."